Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Moore's Complaint (note wording)
2
Oct 04, 2010 12:32PM

On or about April 2010 PTSC became aware that TPL without notice or authorization had commingled an MMP Portfolio license with other portfolios, including, upon information and belief, the "chipscale" portfolio in which TPL then had no rights and other portfolios owned by TPL and licensed the result to a major Silicon Valley electronics and cell phone firm. The major component,by any measure, of that license was a license of the MMP Portfolio.

Share
New Message
Please login to post a reply